A Baby From Three
By Govind Vijaykumar,
The Asian Age
| 03. 08. 2015
[Quotes CGS's Marcy Darnovsky]
Untitled Document
Within a year, the world could see the first of what’s being described as the three-parent baby. And it’s one of mankind’s riskiest endeavours
There’s currently tension within the world’s scientific community. Groups are hurling accusations at each other — ranging from manipulation of data, blatant disregard for human life and for having the sort of enthusiasm that kills off any lab-based endeavour. Whilst one group prepares to announce to the world a life-changing procedure, the other maintains that we have collectively jumped the gun.
All this over a baby… the first ever to be born as a result of modification, rather than just natural progression — a child born from three different humans.
What it’s all about
The idea is simple. A procedure will replace faulty, trouble-causing DNA in the mother’s egg with healthy DNA from a donor woman allowing the child to possess, for the first time in our evolutionary history, genetic inputs from two mothers and one father. Proponents of this technique believe an injection of healthy donor DNA will cancel out life-threatening genetic conditions...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...